RPRX logo

Royalty Pharma (RPRX) EBIT

Annual EBIT

$1.56 B
-$330.95 M-17.54%

December 31, 2024


Summary


Performance

RPRX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRPRXprofitabilitymetrics:

Quarterly EBIT

$400.11 M
-$472.75 M-54.16%

December 31, 2024


Summary


Performance

RPRX Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRPRXprofitabilitymetrics:

TTM EBIT

$1.56 B
-$364.73 M-18.99%

December 31, 2024


Summary


Performance

RPRX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRPRXprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

RPRX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-17.5%-47.7%-17.5%
3 y3 years+10.6%-47.7%-17.5%
5 y5 years-43.0%-47.7%-17.5%

RPRX EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-17.5%+272.3%-54.2%+171.1%-19.0%+272.3%
5 y5-year-43.0%+272.3%-73.5%+171.1%-47.5%+272.3%
alltimeall time-43.0%+272.3%-73.5%+171.1%-47.5%+272.3%

Royalty Pharma EBIT History

DateAnnualQuarterlyTTM
Dec 2024
$1.56 B(-17.5%)
$400.11 M(-54.2%)
$1.56 B(-19.0%)
Sep 2024
-
$872.86 M(+258.6%)
$1.92 B(+57.9%)
Jun 2024
-
$243.39 M(+509.1%)
$1.22 B(-11.3%)
Mar 2024
-
$39.96 M(-94.8%)
$1.37 B(-27.3%)
Dec 2023
$1.89 B(+351.5%)
$764.84 M(+355.0%)
$1.89 B(+237.4%)
Sep 2023
-
$168.11 M(-57.8%)
$559.36 M(-15.1%)
Jun 2023
-
$398.29 M(-28.4%)
$658.64 M(-17.6%)
Mar 2023
-
$556.04 M(-198.8%)
$798.92 M(+91.1%)
Dec 2022
$418.02 M(-70.3%)
-$563.08 M(-310.6%)
$418.02 M(-61.4%)
Sep 2022
-
$267.39 M(-50.4%)
$1.08 B(+0.1%)
Jun 2022
-
$538.56 M(+207.5%)
$1.08 B(-22.0%)
Mar 2022
-
$175.15 M(+74.0%)
$1.39 B(-1.5%)
Dec 2021
$1.41 B
$100.64 M(-62.2%)
$1.41 B(-17.8%)
DateAnnualQuarterlyTTM
Sep 2021
-
$266.12 M(-68.5%)
$1.71 B(-18.5%)
Jun 2021
-
$844.18 M(+329.8%)
$2.10 B(+11.0%)
Mar 2021
-
$196.39 M(-51.4%)
$1.89 B(+1.8%)
Dec 2020
$1.86 B(-31.9%)
$404.47 M(-38.3%)
$1.86 B(-37.3%)
Sep 2020
-
$655.70 M(+3.1%)
$2.96 B(+5.2%)
Jun 2020
-
$636.16 M(+291.1%)
$2.82 B(+16.0%)
Mar 2020
-
$162.68 M(-89.2%)
$2.43 B(-11.0%)
Dec 2019
$2.73 B(+51.9%)
$1.51 B(+196.7%)
$2.73 B(+123.7%)
Sep 2019
-
$508.82 M(+105.2%)
$1.22 B(+71.5%)
Jun 2019
-
$247.94 M(-46.5%)
$711.30 M(+53.5%)
Mar 2019
-
$463.36 M
$463.36 M
Dec 2018
$1.80 B(+13.0%)
-
-
Dec 2017
$1.59 B
-
-

FAQ

  • What is Royalty Pharma annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Royalty Pharma?
  • What is Royalty Pharma annual EBIT year-on-year change?
  • What is Royalty Pharma quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Royalty Pharma?
  • What is Royalty Pharma quarterly EBIT year-on-year change?
  • What is Royalty Pharma TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Royalty Pharma?
  • What is Royalty Pharma TTM EBIT year-on-year change?

What is Royalty Pharma annual earnings before interest & taxes?

The current annual EBIT of RPRX is $1.56 B

What is the all time high annual EBIT for Royalty Pharma?

Royalty Pharma all-time high annual earnings before interest & taxes is $2.73 B

What is Royalty Pharma annual EBIT year-on-year change?

Over the past year, RPRX annual earnings before interest & taxes has changed by -$330.95 M (-17.54%)

What is Royalty Pharma quarterly earnings before interest & taxes?

The current quarterly EBIT of RPRX is $400.11 M

What is the all time high quarterly EBIT for Royalty Pharma?

Royalty Pharma all-time high quarterly earnings before interest & taxes is $1.51 B

What is Royalty Pharma quarterly EBIT year-on-year change?

Over the past year, RPRX quarterly earnings before interest & taxes has changed by -$364.73 M (-47.69%)

What is Royalty Pharma TTM earnings before interest & taxes?

The current TTM EBIT of RPRX is $1.56 B

What is the all time high TTM EBIT for Royalty Pharma?

Royalty Pharma all-time high TTM earnings before interest & taxes is $2.96 B

What is Royalty Pharma TTM EBIT year-on-year change?

Over the past year, RPRX TTM earnings before interest & taxes has changed by -$330.95 M (-17.54%)